193 related articles for article (PubMed ID: 10930993)
1. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
[TBL] [Abstract][Full Text] [Related]
3. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
5. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.
Aref S; Salama O; Al-Tonbary Y; Mansour A
Hematology; 2004 Apr; 9(2):113-21. PubMed ID: 15203866
[TBL] [Abstract][Full Text] [Related]
6. Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells.
Karawajew L; Wuchter C; Ruppert V; Drexler H; Gruss HJ; Dörken B; Ludwig WD
Leukemia; 1997 Aug; 11(8):1245-52. PubMed ID: 9264377
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma in children.
Pituch-Noworolska A; Hajto B; Balwierz W; Klus K
Haematologia (Budap); 2001; 31(3):191-207. PubMed ID: 11855781
[TBL] [Abstract][Full Text] [Related]
8. 99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response.
Sükan A; Yapar Z; SAhin B; Kara O; Fuat Yapar A; CEtiner S; Kibar M
Nucl Med Commun; 2004 Aug; 25(8):777-85. PubMed ID: 15266171
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.
Karawajew L; Ruppert V; Wuchter C; Kösser A; Schrappe M; Dörken B; Ludwig WD
Blood; 2000 Jul; 96(1):297-306. PubMed ID: 10891465
[TBL] [Abstract][Full Text] [Related]
10. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
[TBL] [Abstract][Full Text] [Related]
11. CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients.
Baryshnikov AYu ; Polosukhina ER; Tupitsin NN; Gavrikova NV; Andreeva LYu ; Zabotina TN; Mayakova SA; Kurmashov VI; Syrkin AB; Kadagidze ZG; Blochin DYu ; Shishkin YuV
Adv Exp Med Biol; 1999; 457():251-8. PubMed ID: 10500800
[TBL] [Abstract][Full Text] [Related]
12. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of CD95, Active Caspase-3, and Bcl-2 Expression in Adult Patients with De Novo Acute Lymphoblastic Leukemia.
Montiel-Cervantes LA; Reyes-Maldonado E; Garcia-Chavez J; Hernandez-Caballero A; Molina-Aguilar R; Garcia-Ruiz Esparza MA; Vela-Ojeda J
Arch Med Res; 2018 Jan; 49(1):44-50. PubMed ID: 29680307
[TBL] [Abstract][Full Text] [Related]
14. Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL.
Kanerva J; Tiirikainen M; Mäkipernaa A; Riikonen P; Möttönen M; Salmi TT; Krusius T; Saarinen-Pihkala UM
Pediatr Hematol Oncol; 1998; 15(1):11-21. PubMed ID: 9509502
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia.
Wuchter C; Ruppert V; Schrappe M; Dörken B; Ludwig WD; Karawajew L
Blood; 2002 Jun; 99(11):4109-15. PubMed ID: 12010814
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
Stamati L; Avgeris M; Kosmidis H; Baka M; Anastasiou T; Piatopoulou D; Scorilas A; Gourgiotis D
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2023-36. PubMed ID: 25982455
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression.
Zhou M; Gu L; Yeager AM; Findley HW
Leukemia; 1998 Nov; 12(11):1756-63. PubMed ID: 9823951
[TBL] [Abstract][Full Text] [Related]
18. BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
Avgeris M; Stamati L; Kontos CK; Piatopoulou D; Marmarinos A; Xagorari M; Baka M; Doganis D; Anastasiou T; Kosmidis H; Gourgiotis D; Scorilas A
Clin Chem Lab Med; 2018 Nov; 56(12):2104-2118. PubMed ID: 30016275
[TBL] [Abstract][Full Text] [Related]
19. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.
Beltinger C; Böhler T; Karawajew L; Ludwig WD; Schrappe M; Debatin KM
Br J Haematol; 1998 Aug; 102(3):722-8. PubMed ID: 9722299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]